My watch list
my.bionity.com  
Login  

Founded in 2017, Cansativa is a GDP-certified pharmaceutical wholesaler licensed for trade in controlled substances and headquartered in Frankfurt am Main, Germany. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating current stigmatization surrounding it, and permanently reducing prices for patients.

Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the industry, it has become one of the largest importers and distributors of medical cannabis in Germany. From its location in Frankfurt am Main, the company supplies pharmacies and pharmaceutical wholesalers throughout Germany.

Cansativa’s founding team is able to build upon two generations of professional experiences in the fields of medicine, law, and strategy.

More about Cansativa
  • News

    Northern Swan invests millions in pharma startup Cansativa

    Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in order to further accelerate the growth of the company and its integration into the wider European market. Cansativa will use this investment to expand its current facilities to become a ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE